This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hangzhou Glubio Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yifeng Xia: Innovator in Pharmaceutical Compounds
Introduction
Yifeng Xia is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on isoindolinone compounds.
Latest Patents
Yifeng Xia holds a patent for isoindolinone compounds and their uses. The patent describes isoindolinone compounds represented by a specific structural formula or pharmaceutically acceptable salts thereof. These compounds can be utilized for the treatment of proliferative disorders. The pharmaceutical compositions include the isoindolinone compound or a salt thereof, along with a pharmaceutically acceptable carrier.
Career Highlights
Yifeng Xia is associated with Hangzhou Glubio Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has led to the creation of valuable pharmaceutical products that have the potential to improve patient outcomes.
Collaborations
Yifeng Xia has collaborated with notable colleagues, including Liqiang Fu and Linglong Kong. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
Yifeng Xia's contributions to the field of pharmaceuticals through his patent on isoindolinone compounds exemplify his commitment to advancing medical science. His work continues to impact the treatment of proliferative disorders, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile